Matthew S Kelly1, Michael G Surette, Marek Smieja, Jeffrey M Pernica, Laura Rossi, Kathy Luinstra, Andrew P Steenhoff, Kristen A Feemster, David M Goldfarb, Tonya Arscott-Mills, Sefelani Boiditswe, Ikanyeng Rulaganyang, Charles Muthoga, Letang Gaofiwe, Tiny Mazhani, John F Rawls, Coleen K Cunningham, Samir S Shah, Patrick C Seed. 1. From the *Botswana-UPenn Partnership, Gaborone, Botswana; †Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina; ‡Department of Medicine, McMaster University, §Department of Pathology and Molecular Medicine, McMaster University, ¶St. Joseph's Healthcare, and ‖Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; **Global Health Center, and ††Division of Pediatric Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; ‡‡Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, British Columbia, Canada; §§University of Botswana School of Medicine, Gaborone, Botswana; ¶¶Department of Molecular Genetics and Microbiology, Center for the Genomics of Microbial Systems, Duke University Medical Center, Durham, North Carolina; and ‖‖Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Abstract
BACKGROUND: Nearly half of child pneumonia deaths occur in sub-Saharan Africa. Microbial communities in the nasopharynx are a reservoir for pneumonia pathogens and remain poorly described in African children. METHODS: Nasopharyngeal swabs were collected from children with pneumonia (N = 204), children with upper respiratory infection symptoms (N = 55) and healthy children (N = 60) in Botswana between April 2012 and April 2014. We sequenced the V3 region of the bacterial 16S ribosomal RNA gene and used partitioning around medoids to cluster samples into microbiota biotypes. We then used multivariable logistic regression to examine whether microbiota biotypes were associated with pneumonia and upper respiratory infection symptoms. RESULTS: Mean ages of children with pneumonia, children with upper respiratory infection symptoms and healthy children were 8.2, 11.4 and 8.0 months, respectively. Clustering of nasopharyngeal microbiota identified 5 distinct biotypes: Corynebacterium/Dolosigranulum-dominant (23%), Haemophilus-dominant (11%), Moraxella-dominant (24%), Staphylococcus-dominant (13%) and Streptococcus-dominant (28%). The Haemophilus-dominant [odds ratio (OR): 13.55; 95% confidence interval (CI): 2.10-87.26], the Staphylococcus-dominant (OR: 8.27; 95% CI: 2.13-32.14) and the Streptococcus-dominant (OR: 39.97; 95% CI: 6.63-241.00) biotypes were associated with pneumonia. The Moraxella-dominant (OR: 3.71; 95% CI: 1.09-12.64) and Streptococcus-dominant (OR: 12.26; 95% CI: 1.81-83.06) biotypes were associated with upper respiratory infection symptoms. In children with pneumonia, HIV infection was associated with a lower relative abundance of Dolosigranulum (P = 0.03). CONCLUSIONS: Pneumonia and upper respiratory infection symptoms are associated with distinct nasopharyngeal microbiota biotypes in African children. A lower abundance of the commensal genus Dolosigranulum may contribute to the higher pneumonia risk of HIV-infected children.
BACKGROUND: Nearly half of childpneumonia deaths occur in sub-Saharan Africa. Microbial communities in the nasopharynx are a reservoir for pneumonia pathogens and remain poorly described in African children. METHODS: Nasopharyngeal swabs were collected from children with pneumonia (N = 204), children with upper respiratory infection symptoms (N = 55) and healthy children (N = 60) in Botswana between April 2012 and April 2014. We sequenced the V3 region of the bacterial 16S ribosomal RNA gene and used partitioning around medoids to cluster samples into microbiota biotypes. We then used multivariable logistic regression to examine whether microbiota biotypes were associated with pneumonia and upper respiratory infection symptoms. RESULTS: Mean ages of children with pneumonia, children with upper respiratory infection symptoms and healthy children were 8.2, 11.4 and 8.0 months, respectively. Clustering of nasopharyngeal microbiota identified 5 distinct biotypes: Corynebacterium/Dolosigranulum-dominant (23%), Haemophilus-dominant (11%), Moraxella-dominant (24%), Staphylococcus-dominant (13%) and Streptococcus-dominant (28%). The Haemophilus-dominant [odds ratio (OR): 13.55; 95% confidence interval (CI): 2.10-87.26], the Staphylococcus-dominant (OR: 8.27; 95% CI: 2.13-32.14) and the Streptococcus-dominant (OR: 39.97; 95% CI: 6.63-241.00) biotypes were associated with pneumonia. The Moraxella-dominant (OR: 3.71; 95% CI: 1.09-12.64) and Streptococcus-dominant (OR: 12.26; 95% CI: 1.81-83.06) biotypes were associated with upper respiratory infection symptoms. In children with pneumonia, HIV infection was associated with a lower relative abundance of Dolosigranulum (P = 0.03). CONCLUSIONS:Pneumonia and upper respiratory infection symptoms are associated with distinct nasopharyngeal microbiota biotypes in African children. A lower abundance of the commensal genus Dolosigranulum may contribute to the higher pneumonia risk of HIV-infectedchildren.
Authors: Wouter A A de Steenhuijsen Piters; Elisabeth A M Sanders; Debby Bogaert Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-08-19 Impact factor: 6.237
Authors: Lisa M McNally; Prakash M Jeena; Kavitha Gajee; Stanley A Thula; A Willem Sturm; Sharon Cassol; Andrew M Tomkins; Hoosen M Coovadia; David Goldblatt Journal: Lancet Date: 2007-04-28 Impact factor: 79.321
Authors: Matthew S Kelly; Kathleen E Wirth; Andrew P Steenhoff; Coleen K Cunningham; Tonya Arscott-Mills; Sefelani C Boiditswe; Mohamed Z Patel; Samir S Shah; Rodney Finalle; Ishmael Makone; Kristen A Feemster Journal: J Pediatric Infect Dis Soc Date: 2014-10-08 Impact factor: 3.164
Authors: Debby Bogaert; Bart Keijser; Susan Huse; John Rossen; Reinier Veenhoven; Elske van Gils; Jacob Bruin; Roy Montijn; Marc Bonten; Elisabeth Sanders Journal: PLoS One Date: 2011-02-28 Impact factor: 3.240
Authors: Matthew S Kelly; Marek Smieja; Kathy Luinstra; Kathleen E Wirth; David M Goldfarb; Andrew P Steenhoff; Tonya Arscott-Mills; Coleen K Cunningham; Sefelani Boiditswe; Warona Sethomo; Samir S Shah; Rodney Finalle; Kristen A Feemster Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240
Authors: Shu Mei Teo; Danny Mok; Kym Pham; Merci Kusel; Michael Serralha; Niamh Troy; Barbara J Holt; Belinda J Hales; Michael L Walker; Elysia Hollams; Yury A Bochkov; Kristine Grindle; Sebastian L Johnston; James E Gern; Peter D Sly; Patrick G Holt; Kathryn E Holt; Michael Inouye Journal: Cell Host Microbe Date: 2015-04-09 Impact factor: 21.023
Authors: Matthew S Kelly; Michael G Surette; Marek Smieja; Laura Rossi; Kathy Luinstra; Andrew P Steenhoff; David M Goldfarb; Jeffrey M Pernica; Tonya Arscott-Mills; Sefelani Boiditswe; Tiny Mazhani; John F Rawls; Coleen K Cunningham; Samir S Shah; Kristen A Feemster; Patrick C Seed Journal: Pediatr Infect Dis J Date: 2018-11 Impact factor: 2.129
Authors: Ellen H A van den Munckhof; Harriet C Hafkamp; Josephine de Kluijver; Ed J Kuijper; Maurits N C de Koning; Wim G V Quint; Cornelis W Knetsch Journal: Respir Res Date: 2020-07-14
Authors: Silvio D Brugger; Sara M Eslami; Melinda M Pettigrew; Isabel F Escapa; Matthew T Henke; Yong Kong; Katherine P Lemon Journal: mSphere Date: 2020-09-09 Impact factor: 4.389
Authors: Wouter A A de Steenhuijsen Piters; Simon P Jochems; Elena Mitsi; Jamie Rylance; Sherin Pojar; Elissavet Nikolaou; Esther L German; Mark Holloway; Beatriz F Carniel; Mei Ling J N Chu; Kayleigh Arp; Elisabeth A M Sanders; Daniela M Ferreira; Debby Bogaert Journal: Nat Commun Date: 2019-07-05 Impact factor: 14.919
Authors: Kim S LeMessurier; Amy R Iverson; Ti-Cheng Chang; Maneesha Palipane; Peter Vogel; Jason W Rosch; Amali E Samarasinghe Journal: Sci Rep Date: 2019-12-18 Impact factor: 4.379
Authors: Stephan Köstlbacher; Astrid Collingro; Tamara Halter; Frederik Schulz; Sean P Jungbluth; Matthias Horn Journal: Nat Commun Date: 2021-06-29 Impact factor: 14.919